Detected ·
Atlas Bio
$11MSeed
Atlas Bio has emerged from stealth, announcing a ~$11M Seed round led by Creandum, with First Momentum Ventures and LEA Partners (who backed an earlier unannounced $2.5M Pre-Seed) also participating, alongside angels Robin Rombach (Black Forest Labs) and Jacques Boitreaud (Chai Discovery). Atlas Bio uses a foundation AI model trained on human RNA data to simulate Phase II trials in 12 weeks, aiming to replace costly, slow drug trials.
- Website
- —
- linkedin.com/company/146636384
- Amount
- $11 000 000 USD
- Stage
- Seed
- Event
- Funding round
- Detected
- 2026-10-28 12:12:20 UTC
- Signal ID
- fe3ef054-93c2-4b77-a356-639d0c8ade63
As the API returns it
{
"id": "fe3ef054-93c2-4b77-a356-639d0c8ade63",
"created_at": "2026-10-28T12:12:20.541554Z",
"company_name": "Atlas Bio",
"company_website_url": null,
"company_linkedin_url": "https://www.linkedin.com/company/146636384",
"event_type": "funding",
"funding_amount": 11000000,
"funding_currency": "USD",
"funding_stage": "seed",
"message": "*Atlas Bio has emerged from stealth, announcing a ~$11M Seed round led by Creandum, with First Momentum Ventures and LEA Partners (who backed an earlier unannounced $2.5M Pre-Seed) also participating, alongside angels Robin Rombach (Black Forest Labs) and Jacques Boitreaud (Chai Discovery). Atlas Bio uses a foundation AI model trained on human RNA data to simulate Phase II trials in 12 weeks, aiming to replace costly, slow drug trials.*"
}